Heart drugs

The BMJ last week draws attention to a study in JAMA about nesiritide. Patients with heart failure treated with the drug were more likely to die in the month following treatment.

Today's Guardian reports a study from the European Heart Journal which looks at adherence to guidelines on treating heart failure. The study looked at six countries including Britain. The study is a "publish-ahead-of-print" one and I tracked it down with the aid of the European Society of Cardiology's press release.